Asst Papa Giovanni XXIII; Oncologia Medica

Bergamo, Lombardy 24127

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Colorectal Cancer, Gastric Cancer

Studies at this site

• A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer — Completed
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer — Completed
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed